Stock CMRA COMERA LIFE SCIENCES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Comera Life Sciences Holdings, Inc.

Equities

CMRA

US20037C1080

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 13:19:23 2024-05-28 EDT 		5-day change 1st Jan Change
0.0229 USD -21.71% Intraday chart for Comera Life Sciences Holdings, Inc. -21.84% -58.36%
01-30 Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes CI
01-30 Comera Life Sciences Holdings, Inc. Announces Changes to Its Board CI

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 136.4 134.1 24.41
Enterprise Value (EV) 1 136.4 128 24.74
P/E ratio -53.6 x -7.26 x -0.7 x
Yield - - -
Capitalization / Revenue 308 x 419 x 38.6 x
EV / Revenue 308 x 400 x 39.1 x
EV / EBITDA -66.9 x -23.5 x -2.38 x
EV / FCF - -70,043,573 x -4,967,899 x
FCF Yield - -0% -0%
Price to Book 749 x -0.28 x -3.29 x
Nbr of stocks (in thousands) 13,242 13,242 19,849
Reference price 2 10.30 10.13 1.230
Announcement Date 22-04-15 22-04-15 23-03-17
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales 1 0.4429 0.3198 0.6331
EBITDA 1 -2.038 -5.449 -10.38
EBIT 1 -2.128 -5.536 -10.47
Operating Margin -480.34% -1,730.79% -1,653.76%
Earnings before Tax (EBT) 1 -2.125 -5.452 -18
Net income 1 -2.125 -5.452 -18
Net margin -479.88% -1,704.58% -2,843.79%
EPS 2 -0.1923 -1.395 -1.758
Free Cash Flow - -1.827 -4.981
FCF margin - -571.17% -786.69%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 22-04-15 22-04-15 23-03-17
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 0.01 - 0.33
Net Cash position 1 - 6.19 -
Leverage (Debt/EBITDA) -0.002533 x - -0.0317 x
Free Cash Flow - -1.83 -4.98
ROE (net income / shareholders' equity) - -172% -811%
ROA (Net income/ Total Assets) - -86.9% -117%
Assets 1 - 6.274 15.33
Book Value Per Share 2 0.0100 -36.70 -0.3700
Cash Flow per Share 2 0.0100 16.30 0.0300
Capex 1 0.01 0.14 0.03
Capex / Sales 2.79% 44.4% 4.52%
Announcement Date 22-04-15 22-04-15 23-03-17
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
COMERA LIFE SCIENCES HOLDINGS, INC. Stock Comera Life Sciences Holdings, Inc.
-58.36% 899K
MODERNA, INC. Stock Moderna, Inc.
+54.05% 63.85B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.02% 41.83B
LONZA GROUP AG Stock Lonza Group AG
+40.01% 40.47B
CELLTRION, INC. Stock Celltrion, Inc.
-10.22% 27.17B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.42% 26.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.60% 18.69B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+2.89% 12.73B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+22.40% 12.11B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.49% 12.07B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. CMRA Stock
  4. Financials Comera Life Sciences Holdings, Inc.